Heron Therapeutics, Inc. (HRTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.91
Day's range
$1

Heron Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 02/13/2026 30.05 M $39.06 M   3.25% 17.64%
CLEARLINE CAPITAL LP 02/17/2026 12.24 M $15.91 M   25.97% 7.18%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 11.19 M $14.54 M   9.24% 6.57%
BLACKROCK, INC. 02/12/2026 10.22 M $13.28 M   2.31% 6.00%
VANGUARD GROUP INC 01/29/2026 9.82 M $12.77 M   16.08% 5.76%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/13/2026 8.75 M $11.38 M   0.00% 5.14%
MILLENNIUM MANAGEMENT LLC 02/17/2026 7.17 M $9.32 M   2,785.24% 4.21%
PALISADE CAPITAL MANAGEMENT, LP 02/17/2026 6.33 M $8.22 M   -13.67% 3.71%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 6.25 M $8.13 M   81.16% 3.67%
TEJARA CAPITAL LTD 02/05/2026 5.13 M $6.67 M   11.80% 3.01%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 4.08 M $5.31 M   12.03% 2.40%
STATE STREET CORP 02/13/2026 3.78 M $4.91 M   3.47% 2.22%
JW ASSET MANAGEMENT, LLC 02/06/2026 3.67 M $4.77 M   11.49% 2.16%
CONGRESS PARK CAPITAL LLC 01/14/2026 3.07 M $3.99 M   6.14% 1.80%
D. E. SHAW & CO., INC. 02/17/2026 3.00 M $3.91 M   -2.72% 1.76%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 2.58 M $3.35 M   0.00% 1.51%
CITADEL ADVISORS LLC 02/17/2026 2.10 M $2.72 M   -22.65% 1.23%
UBS GROUP AG 01/29/2026 2.09 M $2.72 M   -28.71% 1.23%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.92 M $2.49 M   -32.89% 1.12%
PALE FIRE CAPITAL SE 02/13/2026 1.47 M $1.91 M   211.90% 0.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.42 M $1.84 M   10.83% 0.83%
JANE STREET GROUP, LLC 02/12/2026 1.37 M $1.78 M   520.90% 0.80%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 1.24 M $1.61 M   45.61% 0.73%
MONACO ASSET MANAGEMENT SAM 02/10/2026 1.23 M $1.60 M   23.00% 0.72%
NORTHERN TRUST CORP 02/17/2026 1.09 M $1.42 M   -5.72% 0.64%
TWO SIGMA INVESTMENTS, LP 02/17/2026 999.51 K $1.30 M   44.38% 0.59%
GOLDMAN SACHS GROUP INC 03/25/2026 989.80 K $1.29 M   -25.29% 0.58%
MORGAN STANLEY 02/13/2026 963.85 K $1.25 M   -60.95% 0.57%
CM MANAGEMENT, LLC 02/02/2026 750.00 K $975.00 K   0.00% 0.44%
ORCHARD CAPITAL MANAGEMENT, LLC 02/12/2026 680.43 K $884.56 K   0.46% 0.40%
SQUAREPOINT OPS LLC 02/13/2026 677.95 K $881.33 K   215.17% 0.40%
RICHMOND BROTHERS, INC. 02/12/2026 572.12 K $743.76 K   0.00% 0.34%
TWO SIGMA ADVISERS, LP 02/17/2026 519.57 K $675.44 K   185.37% 0.31%
NEXPOINT ASSET MANAGEMENT, L.P. 02/17/2026 475.75 K $618.48 K   0.00% 0.28%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 440.25 K $572.33 K   100.00% 0.26%
BANK OF NEW YORK MELLON CORP 02/10/2026 418.48 K $544.02 K   1.46% 0.25%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 376.30 K $489.19 K   -80.57% 0.22%
NUVEEN, LLC 02/12/2026 347.07 K $451.19 K   0.00% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 340.25 K $442.32 K   3.43% 0.20%
CAPTION MANAGEMENT, LLC 02/17/2026 339.10 K $440.83 K   100.00% 0.20%
INVESCO LTD. 02/19/2026 307.86 K $400.22 K   33.05% 0.18%
BARCLAYS PLC 02/13/2026 303.21 K $394.17 K   8.54% 0.18%
APEIRON RIA LLC 02/03/2026 259.97 K $358.76 K   16.64% 0.15%
PALUMBO WEALTH MANAGEMENT LLC 01/21/2026 259.41 K $337.24 K   19.82% 0.15%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/11/2026 248.57 K $283.37 K   0.87% 0.15%
CYNDEO WEALTH PARTNERS, LLC 01/07/2026 248.09 K $322.51 K   0.00% 0.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 242.00 K $314.60 K   -65.43% 0.14%
XTX TOPCO LTD 02/17/2026 240.20 K $312.26 K   687.61% 0.14%
QUADRATURE CAPITAL LTD 02/17/2026 227.78 K $296.12 K   100.00% 0.13%
RHUMBLINE ADVISERS 02/13/2026 203.32 K $264.31 K   -9.50% 0.12%

Heron Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 273 institutional investors and hedge funds held shares of Heron Therapeutics Inc. The most heavily invested institutionals were:

Tejara Capital Ltd: 6.34 M

Congress Park Capital LLC: 4.03 M

JW Asset Management, LLC: 3.75 M

NEW YORK STATE COMMON RETIREMENT FUND: 2.58 M

UBS Group AG: 2.29 M

Richmond Brothers, Inc.: 1.44 M

91.86% of Heron Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 187.81 M shares in the last 24 months. This purchase volume represents approximately $187.81 M in transactions.